CorMedix (CRMD) Return on Capital Employed (2011 - 2025)
CorMedix's (CRMD) quarterly Return on Capital Employed came in at 5.13% in Q4 2025, up 1143.0% year-on-year from 0.41% in Q4 2024, and down 84.56% quarter-over-quarter from 33.21% in Q3 2025.
CorMedix (CRMD) Return on Capital Employed (2011 - 2025) Analysis & Trends
CorMedix has disclosed Return on Capital Employed across 13 years of filings, most recently posting 5.13% for Q4 2025.
- Return on Capital Employed for Q4 2025 came in at 5.13%, up 1143.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 5.13% (up 1143.0% YoY), and the FY2025 annual result was 10.56%, up 1666.0% from the prior year.
- Return on Capital Employed came in at 5.13% for Q4 2025 at CorMedix, down from 33.21% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 39.92% in Q2 2025 to a low of 112.32% in Q2 2024.
- The 5-year median for Return on Capital Employed is 48.43% (2022), against an average of 41.13%.
- Across the five-year window, Return on Capital Employed tumbled 4101 bps in 2024 and soared 15224 bps in 2025, its largest moves.
- CorMedix's Return on Capital Employed stood at 44.05% in 2021, then dropped by 25 bps to 54.93% in 2022, then decreased by 18 bps to 64.98% in 2023, then soared by 90 bps to 6.3% in 2024, then soared by 181 bps to 5.13% in 2025.
- The last three Return on Capital Employed figures came in at 5.13% (Q4 2025), 33.21% (Q3 2025), and 39.92% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -107.40% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -50.43% |
| 10 | CorMedix | 631,378.03 | -154.57 Mn | 107.31 Mn | 5.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.13% |
| Sep 30, 2025 | 33.21% |
| Jun 30, 2025 | 39.92% |
| Mar 31, 2025 | 32.83% |
| Dec 31, 2024 | -6.30% |
| Sep 30, 2024 | -103.63% |
| Jun 30, 2024 | -112.32% |
| Mar 31, 2024 | -83.42% |
| Dec 31, 2023 | -64.98% |
| Sep 30, 2023 | -62.62% |
| Jun 30, 2023 | -75.22% |
| Mar 31, 2023 | -61.84% |
| Dec 31, 2022 | -54.93% |
| Sep 30, 2022 | -50.15% |
| Jun 30, 2022 | -51.77% |
| Mar 31, 2022 | -46.71% |
| Dec 31, 2021 | -44.05% |
| Sep 30, 2021 | -38.05% |
| Jun 30, 2021 | -32.46% |
| Mar 31, 2021 | -45.22% |